3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 250mg

6-Nitro-2H-1,4-benzoxazin-3(4H)-one, 97.0%, 10g

ethyl 3-[(3-phenylpropyl)amino]propanoate, 95.0%, 2g

ethyl 5-{[1,1'-biphenyl]-4-yl}-1H-pyrazole-3-carboxylate, 95.0%, 5g

2-Chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 95.0%, 25g

2-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide, 95.0%, 1g

5-Iodo-2-nitrobenzoic acid, 95.0%, 1g

Ethyl 5-amino-4-(3-methoxyphenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxylate, 97%, 250mg

2,5-Dibromohexane (mixture of diastereoisomers)>98.0%(GC)5g

2-Azetidinecarboxylic acid, 1-methyl-, (2S)-, 95.0%, 500mg

Bis[2-(trimethylsilyloxy)ethyl] Ether>98.0%(GC)5g

Tetrabutylammonium p-Toluenesulfonate>98.0%(T)25g

2-Chloro-5-ethylpyrimidine, 97.0%, 100g